| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer
1 company
Bozigian Haig P. is a Chief Development Officer at NEUROCRINE BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 20 sells.
Estimated insider holdings value: $25.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2021 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sell | 4,546 | $116.33 | $528,857.09 | -0.7% | |
| Nov 12, 2020 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sell | 2,257 | $90.74 | $204,806.50 | -1.5% | |
| Aug 5, 2020 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sell | 2,257 | $118.89 | $268,324.35 | -1.5% | |
| May 12, 2020 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sale+OE | 61,555 | $114.94 | $7,075,396.39 | -9.4% | |
| Apr 24, 2020 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sell | 1,934 | $99.46 | $192,351.19 | -1.3% | |
| Feb 7, 2020 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sell | 1,623 | $103.33 | $167,701.67 | -1.1% | |
| Feb 6, 2020 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sell | 3,441 | $102.43 | $352,448.97 | -0.8% | |
| Jul 30, 2019 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sale+OE | 44,356 | $92.77 | $4,114,857.63 | -13.5% | |
| Jul 15, 2019 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sale+OE | 30,680 | $87.50 | $2,684,506.14 | -17.8% | |
| Jul 11, 2019 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sale+OE | 7,220 | $87.63 | $632,716.64 | -2.5% |